Pale Fire Capital Se Ngm Biopharmaceuticals Inc Transaction History

Pale Fire Capital Se

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $1,860 - $4,061	-3,100 Reduced 9.17%	30,700 $26.4 Million
Q3 2023 Nov 13, 2023	BUY	$1.05 - $3.37 $35,490 - $113,906	33,800 New	33,800 $36.2 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

Stay updated on Pale Fire Capital Se with notifications on news.